Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
7 Nov 23
8-K
Entry into a Material Definitive Agreement
3 Nov 23
8-K
Departure of Directors or Certain Officers
27 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Entry into a Material Definitive Agreement
26 Sep 23
8-K
Other Events
12 Sep 23
8-K
Entry into a Material Definitive Agreement
28 Aug 23
8-K
Regulation FD Disclosure
21 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
Entry into a Material Definitive Agreement
10 Aug 23
NT 10-Q
Notice of late quarterly filing
7 Aug 23
8-K
Regulation FD Disclosure
1 Aug 23
POS AM
Prospectus update (post-effective amendment)
18 Jul 23
8-K
Regulation FD Disclosure
13 Jul 23
8-K
Entry into a Material Definitive Agreement
7 Jul 23
POS AM
Prospectus update (post-effective amendment)
21 Jun 23
8-K
Regulation FD Disclosure
20 Jun 23
8-K
Regulation FD Disclosure
15 Jun 23
8-K
Regulation FD Disclosure
18 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Regulation FD Disclosure
15 May 23
POS AM
Prospectus update (post-effective amendment)
12 May 23
NT 10-Q
Notice of late quarterly filing
8 May 23
8-K
Regulation FD Disclosure
2 May 23
8-K
Regulation FD Disclosure
25 Apr 23
8-K
Other Events
20 Apr 23
8-K
Other Events
20 Apr 23
25-NSE
Exchange delisting
12 Apr 23
8-K/A
Other Events
10 Apr 23
8-K
Other Events
10 Apr 23
8-K
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
30 Mar 23
8-K
Court Confirms Sorrento Therapeutics, Inc.’s $125 Million Arbitration Award Against NantPharma, LLC
17 Mar 23
10-K
2022 FY
Annual report
15 Mar 23
NT 10-K
Notice of late annual filing
28 Feb 23
8-K
Bankruptcy or Receivership
21 Feb 23
8-K
Other Events
21 Feb 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Feb 23
8-K
Bankruptcy or Receivership
13 Feb 23
8-K
Other Events
13 Feb 23
8-K
Regulation FD Disclosure
2 Feb 23
Latest ownership filings
SC 13G/A
Celularity Inc
5 Oct 23
4
Celularity Inc
5 Oct 23
SC 13D/A
Scilex Holding Co
26 Sep 23
4
Scilex Holding Co
25 Sep 23
SC 13D/A
Scilex Holding Co
14 Aug 23
4
Henry Ji
20 Mar 23
SC 13G/A
STATE STREET CORP
10 Mar 23
SC 13G/A
BlackRock Inc.
8 Mar 23
SC 13D/A
Scilex Holding Co
3 Mar 23
SC 13G
ICS OPPORTUNITIES, LTD.
17 Feb 23
SC 13G/A
STATE STREET CORP
9 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
5
Kim Janda
6 Feb 23
SC 13G/A
BlackRock Inc.
3 Feb 23
SC 13D/A
Scilex Holding Co
23 Jan 23
4
Scilex Holding Co
23 Jan 23
4
Henry Ji
23 Dec 22
4
Henry Ji
16 Dec 22
4
Scilex Holding Co
2 Dec 22
4
Scilex Holding Company/DE
25 Nov 22
4
Scilex Holding Company/DE
23 Nov 22
4
Scilex Holding Company/DE
22 Nov 22
SC 13D
Scilex Holding Company/DE
17 Nov 22
4
Vickers Vantage Corp. I
15 Nov 22
3
Vickers Vantage Corp. I
15 Nov 22
4
Henry Ji
7 Sep 22
4
Henry Ji
6 Sep 22
4
Henry Ji
2 Sep 22
4
Henry Ji
26 Aug 22
4
Henry Ji
25 Aug 22
SC 13G
STATE STREET CORP
11 Jul 22
4
Henry Ji
14 Jun 22
4
ELIZABETH CZEREPAK
20 May 22
4
Tammy Reilly
20 May 22
3
Tammy Reilly
20 May 22
SC 13G
VANGUARD GROUP INC
10 Feb 22
SC 13G/A
BlackRock Inc.
7 Feb 22
4
Kim Janda
27 Dec 21
4
ELIZABETH CZEREPAK
18 Nov 21
3
ELIZABETH CZEREPAK
18 Nov 21